Eco Animal Health Group’s (EAH) Buy Rating Reaffirmed at Peel Hunt
Separately, Liberum Capital reaffirmed a buy rating and set a GBX 725 ($9.35) price objective on shares of Eco Animal Health Group in a research report on Monday, July 2nd.
EAH stock opened at GBX 491 ($6.33) on Tuesday. Eco Animal Health Group has a fifty-two week low of GBX 485 ($6.26) and a fifty-two week high of GBX 680 ($8.77).
In related news, insider Anthony Paul Rawlinson sold 60,000 shares of the company’s stock in a transaction dated Tuesday, August 28th. The stock was sold at an average price of GBX 500 ($6.45), for a total transaction of £300,000 ($386,996.90).
About Eco Animal Health Group
ECO Animal Health Group plc develops and markets pharmaceutical products for animals worldwide. The company offers Aivlosin, a macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry. It also provides generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.
Receive News & Ratings for Eco Animal Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eco Animal Health Group and related companies with MarketBeat.com's FREE daily email newsletter.